ImmunityBio Inc is a late-clinical-stage immunotherapy company developing next-generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Richard Adcock$3.5B
Market Cap • 25/04/20242014
(há 10 anos)
2021
(3 years ago)
NASDAQ
Listagem
San Diego
Sede • California725
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
IBRXSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.